Korean Drug Co., Ltd. (KOSDAQ:014570)
South Korea · Delayed Price · Currency is KRW 3,955.00
-25.00 (-0.63%)
At close: Mar 31, 2026
Korean Drug Revenue
In the year 2025, Korean Drug had annual revenue of 62.51B KRW, down -14.37%. Korean Drug had revenue of 18.00B in the quarter ending December 31, 2025, with 1.67% growth.
Revenue
62.51B
Revenue Growth
-14.37%
P/S Ratio
0.69
Revenue / Employee
231.51M
Employees
270
Market Cap
43.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 62.51B | -10.49B | -14.37% |
| Dec 31, 2024 | 73.00B | -8.37B | -10.29% |
| Dec 31, 2023 | 81.37B | 1.39B | 1.74% |
| Dec 31, 2022 | 79.98B | 5.52B | 7.41% |
| Dec 31, 2021 | 74.47B | 7.68B | 11.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korea Arlico Pharm | 201.20B |
| RP Bio | 134.21B |
| Jin Yang Pharmaceutical | 120.69B |
| GeneBioTech Co. ,Ltd | 90.79B |
| Sinil Pharmaceutical | 80.56B |
| ChoA Pharmaceutical Co., LTD. | 59.31B |
| Kyung Nam Pharm | 56.18B |
| Seoul Pharma | 52.15B |